Human CCL17/TARC Quantikine ELISA Kit
| Name | Human CCL17/TARC Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DDN00 |
| Category | ELISA Kit |
| Prices | $509.00, $2,440.00, $16,540.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL) |
| Sensitivity | 7 pg/mL |
| Range | 31.2 - 2,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human TARC Immunoassay kit is a 3.5 hour solid phase ELISA designed to measure TARC in cell culture supernates, serum, and plasma |
| Gene | CCL17 |
| Supplier Page | Shop |
Product images
Product References
Expansion of activated regulatory T cells by myeloid-specific chemokines via an - Expansion of activated regulatory T cells by myeloid-specific chemokines via an
Shi G, Han J, Liu G, Hao Y, Ma Y, Li T, Wu X, Zhang H, Liu Y, Wang B, Kong Y, Zhou J, Zeng H. Eur J Immunol. 2014 Feb;44(2):420-30.
Prognostic significance of pretreatment serum cytokines in classical Hodgkin - Prognostic significance of pretreatment serum cytokines in classical Hodgkin
Marri PR, Hodge LS, Maurer MJ, Ziesmer SC, Slager SL, Habermann TM, Link BK, Cerhan JR, Novak AJ, Ansell SM. Clin Cancer Res. 2013 Dec 15;19(24):6812-9.
BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and - BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and
Pranzatelli MR, Tate ED, McGee NR, Travelstead AL, Colliver JA, Ness JM, Ransohoff RM. J Neuroinflammation. 2013 Jan 16;10:10.
Regulatory T cells suppress T cell activation at the pathologic site of human - Regulatory T cells suppress T cell activation at the pathologic site of human
Rai AK, Thakur CP, Singh A, Seth T, Srivastava SK, Singh P, Mitra DK. PLoS One. 2012;7(2):e31551.
Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of - Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of
Oo YH, Weston CJ, Lalor PF, Curbishley SM, Withers DR, Reynolds GM, Shetty S, Harki J, Shaw JC, Eksteen B, Hubscher SG, Walker LS, Adams DH. J Immunol. 2010 Mar 15;184(6):2886-98.
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. - Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.
Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, Forero-Torres A. N Engl J Med. 2010 Nov 4;363(19):1812-21.
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant - Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant
Roufosse F, de Lavareille A, Schandene L, Cogan E, Georgelas A, Wagner L, Xi L, Raffeld M, Goldman M, Gleich GJ, Klion A. J Allergy Clin Immunol. 2010 Oct;126(4):828-835.e3. doi:
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. - Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.
Beck LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R, Paller AS, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes KC, Leung DY. J Allergy Clin Immunol. 2009 Aug;124(2):260-9, 269.e1-7. doi:
The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one - The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one
Narbutt J, Lesiak A, Sysa-Jedrzeiowska A, Zakrzewski M, Bogaczewicz J, Stelmach I, Kuna P. Mediators Inflamm. 2009;2009:269541.
Increases in serum TARC/CCL17 levels are associated with progression-free - Increases in serum TARC/CCL17 levels are associated with progression-free
Cornforth AN, Lee GJ, Fowler AW, Carbonell DJ, Dillman RO. J Clin Immunol. 2009 Sep;29(5):657-64.